In 2007 New Zealand (NZ) became the first country to make oseltamivir (Tamiflu®) available off-prescription. This study investigated the extent of pharmacist supply of oseltamivir over 5 years, including during the influenza A(H1N1) pandemic, and the impact of pharmacist supply of oseltamivir on influenza virus oseltamivir susceptibility, personal stockpiling and influenza vaccine uptake.
Pharmacology, Toxicology and Pharmaceutical Science
5
13%
Biochemistry, Genetics and Molecular Biology
3
8%
Agricultural and Biological Sciences
3
8%
Immunology and Microbiology
2
5%
Other
6
15%
Unknown
10
25%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2026.
All research outputs
#1,757,109
of 34,410,798 outputs
Outputs from Journal of Antimicrobial Chemotherapy (JAC)
#459
of 10,371 outputs
Outputs of similar age
#9,384
of 224,397 outputs
Outputs of similar age from Journal of Antimicrobial Chemotherapy (JAC)
#4
of 110 outputs
Altmetric has tracked 34,410,798 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,371 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 224,397 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.
